TY  - CONF
  - Pressler, RM,Boylan, G,De Vries, LS,Marlow, N,Vanhatalo, S,Jullien, V,Zohar, S,Mats, B,Hallberg, B,Cross, JH,Chiron, C,Levene, M,Mangum, B,Pons, G,Hellstrom-Westas, L,Murphy, B,Murray, D,Rennie, J,Swarte, R,Toet, M,NEMO Consortium
  - BUMETANIDE AND HEARING LOSS: RESULTS OF A PHASE I/II DOSE FINDING AND FEASIBILITY TRIAL OF BUMETANIDE FOR SECOND LINE TREATMENT OF NEONATAL SEIZURES (NEMO)
  - EPILEPSIA
  - 2014
  - June
  - Validated
  - 1
  - ()
  - 215
  - 215
DA  - 2014/06
ER  - 

@inproceedings{V271355116,
   = {Pressler,  RM and Boylan,  G and De Vries,  LS and Marlow,  N and Vanhatalo,  S and Jullien,  V and Zohar,  S and Mats,  B and Hallberg,  B and Cross,  JH and Chiron,  C and Levene,  M and Mangum,  B and Pons,  G and Hellstrom-Westas,  L and Murphy,  B and Murray,  D and Rennie,  J and Swarte,  R and Toet,  M and NEMO Consortium },
   = {BUMETANIDE AND HEARING LOSS: RESULTS OF A PHASE I/II DOSE FINDING AND FEASIBILITY TRIAL OF BUMETANIDE FOR SECOND LINE TREATMENT OF NEONATAL SEIZURES (NEMO)},
   = {{EPILEPSIA}},
   = {2014},
   = {June},
   = {Validated},
   = {1},
   = {()},
  pages = {215--215},
  source = {IRIS}
}